Issue number:
08/2012
Date Issued:
30 Mar 2012
Issued to:
Public Hospitals
Purpose:
To advise hospitals of changes to the Highly Specialised Drugs Program, effective 1 April 2012.

NEW BRANDS

Mycophenolate Mofetil
APO-Mycophenolate             TX                        
Ceptolate                             AF               
Imulate                                QA
Mycophenolate Sandoz        SZ
Newly listed brands subsidised for both  9501C - Capsule 250mg and 9502D- Tablet 500mg

DELETED ITEMS

Epoprostenol Sodium
5731P           Powder for IV infusion 500mcg (base) with diluent          Flolan
5732Q           Powder for IV infusion 1.5mg (base) with diluent            Flolan

RESTRICTION ALTERATIONS

Ambrisentan
Bosentan Monohydrate
Epoprostenol Sodium
Iloprost Trometamol
Sildenafil Citrate
Complex Authority Required - alterations recognise listing of Tadalafil on 1 April 2012.

Abatacept
Infliximab
Rituximab
Tocilizumab
Complex Authority Required - updated to recognise other listed DMARDs.

REIMBURSEMENT REDUCTIONS

Clarithromycin
5624B           Tablet 500mg           100              from $68.63 to $55.32
5625C           Tablet 250mg           100              from $34.31 to $27.71

Clozapine
5626D           Tablet 50mg             100              from $135.54 to $99.99
5627E           Tablet 200mg           100              from $508.25 to $374.94
5628F           Tablet 25mg             100              from $67.76 to $49.99
5629G           Tablet 100mg           100              from $254.12 to $187.46

Efavirenz
5707J            Oral solution 30mg/mL      7 x 180mL               from $950.53 to $570.29
5706H           Tablet 600mg                    60                          from $905.28 to $543.16
5708K           Tablet 200mg                    180                        from $905.28 to $543.16

Epoprostenol
5030R           Powder for IV infusion         1                           from $41.69 to $39.62
                    500mcg (base) infusion
                    administration set
5035B           Powder for IV infusion         1                           from $83.37 to $79.23
                    1.5mg (base) infusion
                    administration set

Mycophenolate Mofetil
9501C           Capsule 250mg                  600                        from $1,111.38 to $933.54
9502D           Tablet 500mg                     300                        from $1,111.38 to $933.54

Mycophenolate Sodium
9503E           Tablet EC 180mg                240                        from $444.56 to $373.44
9504F           Tablet EC 360mg                240                        from $889.12 to $746.86

Tenofovir with Emtricitabine and Efavirenz
9565K           Tablet 300mg with 200mg and 600mg       60      from $2,435.48 to $2,073.36

REIMBURSEMENT INCREASES

Foscarnet Sodium
5747L           IV infusion 24mg/mL           6 x 250ml                from $395.00 to $1,177.50

Further information on the changes including the full restrictions can be found at www.health.vic.gov.au/hsdp or http://www.pbs.gov.au/browse/section100-hb

Maree Guyatt
Director, Integrated Care

Changes notified by hospital circular will be updated in the Guidelines on the internet and the claim form amended. WEB SITE ADDRESS: www.health.vic.gov.au/hsdp